Formulas for special medical purposes for the elderly are foods specially processed and formulated to meet the special needs of kidney disease patients for nutrients or meals. The product formula is characterized by being based on fully nutritious formula foods for the corresponding age groups and appropriately adjusting the special needs of nutrients based on the pathophysiological characteristics of kidney disease. It can be used as a single nutritional source to meet the nutritional needs of patients with kidney disease.
The global Formulas for Special Medical Purposes for Infants and Young Children market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Formulas for Special Medical Purposes for Infants and Young Children is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Formulas for Special Medical Purposes for Infants and Young Children is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Formulas for Special Medical Purposes for Infants and Young Children include Abbott, 狈别蝉迟濒茅, NUTRICIA, Fresenius, Ajinomoto, MeadJohnson, BOSSD, Bayer and EnterNutr, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Formulas for Special Medical Purposes for Infants and Young Children, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Formulas for Special Medical Purposes for Infants and Young Children.
Report Scope
The Formulas for Special Medical Purposes for Infants and Young Children market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Formulas for Special Medical Purposes for Infants and Young Children market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Formulas for Special Medical Purposes for Infants and Young Children manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Abbott
狈别蝉迟濒茅
NUTRICIA
Fresenius
Ajinomoto
MeadJohnson
BOSSD
Bayer
EnterNutr
Anhui New Health Biotechnology
Bangsidi Biotechnology
Dongze Special Medical Food
Special Biotechnology
Haisike Pharmaceutical
Xi'an Libang Clinical Nutrition
Segment by Type
Gel Food
Porous Food
Powdered Food
Pasty Food
Milky Food
Others
Segment by Application
Hospital
Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Formulas for Special Medical Purposes for Infants and Young Children manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Formulas for Special Medical Purposes for Infants and Young Children in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Overview
1.1 Product Overview and Scope of Formulas for Special Medical Purposes for Infants and Young Children
1.2 Formulas for Special Medical Purposes for Infants and Young Children Segment by Type
1.2.1 Global Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Gel Food
1.2.3 Porous Food
1.2.4 Powdered Food
1.2.5 Pasty Food
1.2.6 Milky Food
1.2.7 Others
1.3 Formulas for Special Medical Purposes for Infants and Young Children Segment by Application
1.3.1 Global Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue 2019-2030
1.4.2 Global Formulas for Special Medical Purposes for Infants and Young Children Sales 2019-2030
1.4.3 Global Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Competition by Manufacturers
2.1 Global Formulas for Special Medical Purposes for Infants and Young Children Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Formulas for Special Medical Purposes for Infants and Young Children Average Price by Manufacturers (2019-2024)
2.4 Global Formulas for Special Medical Purposes for Infants and Young Children Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Formulas for Special Medical Purposes for Infants and Young Children, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Formulas for Special Medical Purposes for Infants and Young Children, Product Type & Application
2.7 Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Competitive Situation and Trends
2.7.1 Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Formulas for Special Medical Purposes for Infants and Young Children Players 麻豆原创 Share by Revenue
2.7.3 Global Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Formulas for Special Medical Purposes for Infants and Young Children Retrospective 麻豆原创 Scenario by Region
3.1 Global Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Formulas for Special Medical Purposes for Infants and Young Children Global Formulas for Special Medical Purposes for Infants and Young Children Sales by Region: 2019-2030
3.2.1 Global Formulas for Special Medical Purposes for Infants and Young Children Sales by Region: 2019-2024
3.2.2 Global Formulas for Special Medical Purposes for Infants and Young Children Sales by Region: 2025-2030
3.3 Global Formulas for Special Medical Purposes for Infants and Young Children Global Formulas for Special Medical Purposes for Infants and Young Children Revenue by Region: 2019-2030
3.3.1 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue by Region: 2019-2024
3.3.2 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue by Region: 2025-2030
3.4 North America Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Facts & Figures by Country
3.4.1 North America Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Formulas for Special Medical Purposes for Infants and Young Children Sales by Country (2019-2030)
3.4.3 North America Formulas for Special Medical Purposes for Infants and Young Children Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Facts & Figures by Country
3.5.1 Europe Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Formulas for Special Medical Purposes for Infants and Young Children Sales by Country (2019-2030)
3.5.3 Europe Formulas for Special Medical Purposes for Infants and Young Children Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Formulas for Special Medical Purposes for Infants and Young Children Sales by Country (2019-2030)
3.6.3 Asia Pacific Formulas for Special Medical Purposes for Infants and Young Children Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Formulas for Special Medical Purposes for Infants and Young Children Sales by Country (2019-2030)
3.7.3 Latin America Formulas for Special Medical Purposes for Infants and Young Children Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Formulas for Special Medical Purposes for Infants and Young Children Sales by Country (2019-2030)
3.8.3 Middle East and Africa Formulas for Special Medical Purposes for Infants and Young Children Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Formulas for Special Medical Purposes for Infants and Young Children Sales by Type (2019-2030)
4.1.1 Global Formulas for Special Medical Purposes for Infants and Young Children Sales by Type (2019-2024)
4.1.2 Global Formulas for Special Medical Purposes for Infants and Young Children Sales by Type (2025-2030)
4.1.3 Global Formulas for Special Medical Purposes for Infants and Young Children Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue by Type (2019-2030)
4.2.1 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue by Type (2019-2024)
4.2.2 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue by Type (2025-2030)
4.2.3 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Formulas for Special Medical Purposes for Infants and Young Children Price by Type (2019-2030)
5 Segment by Application
5.1 Global Formulas for Special Medical Purposes for Infants and Young Children Sales by Application (2019-2030)
5.1.1 Global Formulas for Special Medical Purposes for Infants and Young Children Sales by Application (2019-2024)
5.1.2 Global Formulas for Special Medical Purposes for Infants and Young Children Sales by Application (2025-2030)
5.1.3 Global Formulas for Special Medical Purposes for Infants and Young Children Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue by Application (2019-2030)
5.2.1 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue by Application (2019-2024)
5.2.2 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue by Application (2025-2030)
5.2.3 Global Formulas for Special Medical Purposes for Infants and Young Children Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Formulas for Special Medical Purposes for Infants and Young Children Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 狈别蝉迟濒茅
6.2.1 狈别蝉迟濒茅 Corporation Information
6.2.2 狈别蝉迟濒茅 Description and Business Overview
6.2.3 狈别蝉迟濒茅 Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.2.4 狈别蝉迟濒茅 Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.2.5 狈别蝉迟濒茅 Recent Developments/Updates
6.3 NUTRICIA
6.3.1 NUTRICIA Corporation Information
6.3.2 NUTRICIA Description and Business Overview
6.3.3 NUTRICIA Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.3.4 NUTRICIA Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.3.5 NUTRICIA Recent Developments/Updates
6.4 Fresenius
6.4.1 Fresenius Corporation Information
6.4.2 Fresenius Description and Business Overview
6.4.3 Fresenius Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.4.5 Fresenius Recent Developments/Updates
6.5 Ajinomoto
6.5.1 Ajinomoto Corporation Information
6.5.2 Ajinomoto Description and Business Overview
6.5.3 Ajinomoto Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ajinomoto Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.5.5 Ajinomoto Recent Developments/Updates
6.6 MeadJohnson
6.6.1 MeadJohnson Corporation Information
6.6.2 MeadJohnson Description and Business Overview
6.6.3 MeadJohnson Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MeadJohnson Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.6.5 MeadJohnson Recent Developments/Updates
6.7 BOSSD
6.6.1 BOSSD Corporation Information
6.6.2 BOSSD Description and Business Overview
6.6.3 BOSSD Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BOSSD Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.7.5 BOSSD Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bayer Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 EnterNutr
6.9.1 EnterNutr Corporation Information
6.9.2 EnterNutr Description and Business Overview
6.9.3 EnterNutr Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.9.4 EnterNutr Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.9.5 EnterNutr Recent Developments/Updates
6.10 Anhui New Health Biotechnology
6.10.1 Anhui New Health Biotechnology Corporation Information
6.10.2 Anhui New Health Biotechnology Description and Business Overview
6.10.3 Anhui New Health Biotechnology Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Anhui New Health Biotechnology Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.10.5 Anhui New Health Biotechnology Recent Developments/Updates
6.11 Bangsidi Biotechnology
6.11.1 Bangsidi Biotechnology Corporation Information
6.11.2 Bangsidi Biotechnology Formulas for Special Medical Purposes for Infants and Young Children Description and Business Overview
6.11.3 Bangsidi Biotechnology Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bangsidi Biotechnology Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.11.5 Bangsidi Biotechnology Recent Developments/Updates
6.12 Dongze Special Medical Food
6.12.1 Dongze Special Medical Food Corporation Information
6.12.2 Dongze Special Medical Food Formulas for Special Medical Purposes for Infants and Young Children Description and Business Overview
6.12.3 Dongze Special Medical Food Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Dongze Special Medical Food Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.12.5 Dongze Special Medical Food Recent Developments/Updates
6.13 Special Biotechnology
6.13.1 Special Biotechnology Corporation Information
6.13.2 Special Biotechnology Formulas for Special Medical Purposes for Infants and Young Children Description and Business Overview
6.13.3 Special Biotechnology Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Special Biotechnology Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.13.5 Special Biotechnology Recent Developments/Updates
6.14 Haisike Pharmaceutical
6.14.1 Haisike Pharmaceutical Corporation Information
6.14.2 Haisike Pharmaceutical Formulas for Special Medical Purposes for Infants and Young Children Description and Business Overview
6.14.3 Haisike Pharmaceutical Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Haisike Pharmaceutical Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.14.5 Haisike Pharmaceutical Recent Developments/Updates
6.15 Xi'an Libang Clinical Nutrition
6.15.1 Xi'an Libang Clinical Nutrition Corporation Information
6.15.2 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Infants and Young Children Description and Business Overview
6.15.3 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Infants and Young Children Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Xi'an Libang Clinical Nutrition Formulas for Special Medical Purposes for Infants and Young Children Product Portfolio
6.15.5 Xi'an Libang Clinical Nutrition Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Formulas for Special Medical Purposes for Infants and Young Children Industry Chain Analysis
7.2 Formulas for Special Medical Purposes for Infants and Young Children Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Formulas for Special Medical Purposes for Infants and Young Children Production Mode & Process
7.4 Formulas for Special Medical Purposes for Infants and Young Children Sales and 麻豆原创ing
7.4.1 Formulas for Special Medical Purposes for Infants and Young Children Sales Channels
7.4.2 Formulas for Special Medical Purposes for Infants and Young Children Distributors
7.5 Formulas for Special Medical Purposes for Infants and Young Children Customers
8 Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Dynamics
8.1 Formulas for Special Medical Purposes for Infants and Young Children Industry Trends
8.2 Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Drivers
8.3 Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Challenges
8.4 Formulas for Special Medical Purposes for Infants and Young Children 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abbott
狈别蝉迟濒茅
NUTRICIA
Fresenius
Ajinomoto
MeadJohnson
BOSSD
Bayer
EnterNutr
Anhui New Health Biotechnology
Bangsidi Biotechnology
Dongze Special Medical Food
Special Biotechnology
Haisike Pharmaceutical
Xi'an Libang Clinical Nutrition
听
听
*If Applicable.